The study provides convincing evidence for variable regeneration efficiency among planarian species that will be of interest to developmental biologists interested in regeneration. However, some of ...

This valuable study characterises the activity of motor units from two of the three anatomical subdivisions ("heads") of the triceps muscle while mice walked on a treadmill at various speeds. Although ...

If so, they could be experiencing upper cervical dysfunction. What do we mean when we say an upper cervical adjustment or ...

IF YOUR MAIN FITNESS goal is to add mass and chisel out your figure, then the thought of building "lean muscle" likely sounds rather appealing. After all, why would you dedicate hours in the gym ...

Muscle rigidity is very common, and it can be uncomfortable. You can have stiff and tense muscles due to various causes—such as sitting or sleeping in the wrong position, or it can be the result of a ...

On Wednesday, Clone Robotics released video footage of its Protoclone humanoid robot, a full-body machine that uses synthetic muscles to create unsettlingly human-like movements. In the video ...

Clone’s Myofiber technology uses artificial muscles to move the skeleton by attaching them to precise bone points, like animals. In December, Clone entered the competitive humanoid robotics ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy ...

In adolescents and young adults, they could be connected to a body image disorder that exhibits a pathological focus on muscle development and leanness, according to new research. “The use of 6 ...

Veru, Eli Lilly, Regeneron, among leaders in muscle-preserving drug development FDA approval criteria for these drugs remains unclear Doctors, analysts focused on health benefits beyond weight ...

Approval would upend two decades of failure for myostatin pathway inhibitors, a class of drugs that grows skeletal muscle. Beyond the first regulatory decision for apitegromab, companies are ...